Skip to main content

Table 1 Patient characteristics

From: Tumor-related gene expression levels in pulmonary pleomorphic carcinoma

Case

Age/Sex

Stage

Chemotherapy

Relapse

 

Status

1

70/M

T2bN1M0

(+)

Distant

16 mo

Dead

AMR

2

75/M

T2bN1M0

(−)

(−)

39 mo

Alive

3

57/M

T2aN0M0

(+)

Distant

42 mo

Alive

AMR, CBDCA + PTX

4

77/M

T2bN0M0

(−)

Distant

9 mo

Dead

5

68/M

T2aN0M0

(+)

(−)

57 mo

Alive

DTX + TS1

6

80/M

T3N0M0

(−)

Distant

57 mo

Alive

7

54/M

T3N0M0

(−)

Locala

2 mo

Dead

8

47/M

T2bN0M0

(+)

Distant

12 mo

Dead

TS1, CDDP + VNR, CBDCA + PTX

9

48/F

T2aN1M1

(+)

Distant

14 mo

Dead

CBDCA + DTX

10

73/M

T2bN0M0

(−)

(−)b

2 mo

Dead

  1. Each stage is presented based on the 7th UICC TNM classification
  2. mo months, AMR amrubicin, CBDCA carboplatin, PTX paclitaxel, TS1 tegafur gimeracil oteracil, DTX docetaxel, VNR vinorelbine
  3. aincomplete resection
  4. boperative death due to cerebral infarction